Ignite Creation Date:
2025-12-25 @ 2:09 AM
Ignite Modification Date:
2026-02-01 @ 10:53 PM
Study NCT ID:
NCT03427060
Status:
COMPLETED
Last Update Posted:
2025-05-04
First Post:
2018-01-24
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Coversin in PNH in Patients With Resistance to Eculizumab Due to Complement C5 Polymorphisms
Sponsor:
AKARI Therapeutics
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Paroxysmal Nocturnal Hemoglobinuria (PNH) | View |
Keywords: